WillItSurvive
Insurance companies · United States

Centene

Centene runs Medicaid, Medicare, and ACA marketplace health plans across 29 US states.

Losing its protection
Assessed 20 July 2026 · Evidence as of 20 July 2026
The structural protection is eroding.
On the recordSince 20 July 2026 · Checkable from late July/August 2026 · Every call on the record Checkpoint: Q2 2026 earnings report testing raised full-year guidance against membership losses
The call

Centene holds the contracts and data that keep states dependent on it, but law changes are shrinking the pool of people it insures faster than it can restructure.

Centene is a health insurance company that serves low-income people on government programs like Medicaid and provides managed care services to state governments. Its contracts with states are long-term and hard to replace because the company has built deep relationships and runs complex systems that would take years for a competitor to copy or for new software to remake. However, the real problem is not competitors but lawmakers: new laws are cutting the number of people eligible for Medicaid, millions of people have already lost coverage in the past year, and more enrollment declines are coming in the next few years, which means Centene's business is literally shrinking by government decree even if the company stays dominant in what remains.

Why
01
AI pressure: None apparent. No AI product replaces state Medicaid contracts or claims processing; AI is a tool Centene buys, not a rival eating its book. Could AI do the core job? Unlikely.
02
Bigger players: UnitedHealth Group (UnitedHealthcare Community Plan) and Elevance Health. Both bid against Centene for the same state Medicaid RFPs and could pick up members Centene loses as rolls shrink. Could a giant copy it? No, they are blocked.
03
What protects it. Multi-year state Medicaid contracts, deep agency integration, and a 29-state claims database competitors can't easily replicate.
What would change this call
Centene's Q2 and Q3 2026 earnings show whether Medicaid and ACA membership stops falling sequentially. Would show if enrollment losses are stabilizing or still accelerating.
Outcome of Centene's 2026 voluntary buyout program and whether involuntary layoffs follow within 6 months. Would show whether cost cuts are contained or deepen into forced layoffs.
State-level Medicaid enrollment data through 2027 tracking OBBBA-driven disenrollment of 5 to 10 million people. Would show how much of Centene's core Medicaid book is being legislated away.
Key numbers
  • Membership fell from 27.9M to 26.3M (2026-06-16)
  • ACA marketplace members dropped 5.5M to 3.5M (2026-03-31)
  • FY2025 revenue $194.8B but GAAP net loss $6.67B (2025-12-31)
Named risks
  • One Big Beautiful Bill Act projected to strip 5-10 million from Medicaid by 2028. Severity: high
  • ACA enrollment decline of 17-26% industry-wide continuing through 2026 after subsidy expiration. Severity: high
  • Involuntary layoffs if June 2026 voluntary buyout targets are not met. Severity: medium
  • Ongoing securities class actions and shareholder derivative suit over 2025 guidance withdrawal. Severity: medium
  • Legacy Centurion fraud and neglect lawsuits in Delaware and Indiana generating reputational exposure. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
UnitedHealth GroupcontestingUnitedHealth in 30 ACA states vs Centene's 29 in 2026, per KFF data dated 2026-07-08
CVS/Aetnagaining onCVS/Aetna exited ACA Marketplace nationwide for plan year 2026, ceding ground to Centene
Molina HealthcarecontestingMolina posts ~$43.1B revenue and competes in 14 ACA states as of 2026-07-06
Oscar HealthcontestingAI-forward ACA rival with ~$13.3B revenue as of 2026-07-06
Questions people ask
Is Centene profitable in 2026?
Yes in Q1 2026: GAAP net earnings hit $1.541 billion and adjusted diluted EPS was $3.37 versus a $2.13 consensus, a 57.9% beat, as of March 31, 2026. This followed a FY2025 GAAP net loss of $6.67 billion driven by a $6.7 billion non-cash goodwill impairment tied to policy changes.
Is Centene doing layoffs?
Centene launched a company-wide voluntary buyout program in June 2026 open to most of its roughly 61,000 employees after steep Medicaid and ACA membership losses, with management explicitly warning that involuntary layoffs could follow if voluntary targets are not met.
Who is Centene's biggest competitor?
UnitedHealth Group is the closest rival, participating in 30 ACA Marketplace states in 2026 versus Centene's 29, per KFF data from July 8, 2026. Notably, CVS/Aetna exited the ACA Marketplace nationwide for plan year 2026, leaving Centene facing less direct competition there.
Could AI replace Centene?
Unlikely soon: Medicaid reimbursement rates are set by state government contracts, not a competitive market AI can undercut. Centene uses AI internally for fraud detection, crediting it with helping lift Medicaid health benefits ratio to 93.1% and adjusted EPS growth of 16.2% year-over-year in Q1 2026.
Who owns Centene?
Centene is a publicly traded company on the NYSE under ticker CNC with no controlling parent, assessed at the consolidated group level. Its market capitalization was approximately $32.8 to $33.1 billion as of July 20, 2026.
What happened to Centene's stock in 2025?
On July 1, 2025, Centene withdrew its FY2025 guidance after an independent actuary (Wakely) found ACA risk-adjustment revenue shortfalls of about $1.8 billion across 22 states. The stock crashed roughly 40% in one day, wiping out more than $11 billion in market cap.
Timeline
  • 2026-07-20Market cap ~$32.8-33.1B; stock trading around $66-67, 52-week range $25.08-$69.36
  • 2026-06-16Delaware AG joins whistleblower fraud suit against former subsidiary Centurion
  • 2026-06-15Centene launches company-wide voluntary buyout program for ~61,000 employees
  • 2026-04-28Q1 2026 results: revenue $49.94B, adjusted EPS $3.37, beat consensus by 57.9%
  • 2026-04-01Carolina Complete Health and WellCare of North Carolina merge into one plan
  • 2026-02-06FY2025 results: $194.8B revenue, $6.67B net loss, 2026 guidance issued
  • 2025-12-31Centene signs deal to divest remaining Magellan Health assets, $513M impairment
  • 2025-07-01Guidance withdrawn after actuary finds $1.8B ACA shortfall; stock crashes ~40%
  • 2023-12-31Centene divests Centurion prison-healthcare subsidiary for $259M
Revision history
20 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources